{
    "timestamp": "Sep 4, 2025 9:30 AM EST",
    "stats": {
        "input_words": 786947,
        "output_words": 553,
        "filings_processed": 7
    },
    "filings": [
        {
            "company_name": "Old Dominion",
            "stock": "ODFL",
            "wiki_url": "https://en.wikipedia.org/wiki/Old_Dominion_Freight_Line",
            "change_percent": -0.98,
            "price": 148.1,
            "filing_type": "8-K",
            "filing_time": "2025-09-04T08:44:08-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/878927/000095017025112956/0000950170-25-112956-index.htm",
            "accession_number": "0000950170-25-112956",
            "summary_points": [
                "1. Old Dominion Freight Line, Inc. reported a 4.8% decrease in revenue per day in August 2025 compared to August 2024, due to lower LTL tons per day, partially offset by increased revenue per hundredweight.",
                "2.  Year-over-year, LTL revenue per hundredweight and LTL revenue per hundredweight (excluding fuel surcharges) increased 4.5% and 4.7%, respectively, for the quarter-to-date period ending September 4, 2025.",
                "3. The company faces numerous risks, including economic downturns, increased costs, and challenges related to retaining key employees and adapting to new technologies."
            ]
        },
        {
            "company_name": "Genuine Parts Company",
            "stock": "GPC",
            "wiki_url": "https://en.wikipedia.org/wiki/Genuine_Parts_Company",
            "change_percent": 0.07,
            "price": 136.27,
            "filing_type": "8-K",
            "filing_time": "2025-09-04T08:43:47-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/40987/000119312525195442/0001193125-25-195442-index.htm",
            "accession_number": "0001193125-25-195442",
            "summary_points": [
                "1. Genuine Parts Company (GPC) entered into a cooperation agreement with Elliott Investment Management L.P. on September 4, 2025, resulting in the immediate appointment of two new independent directors to GPC's board and  retention awards for its named executive officers.",
                "2.  As of September 4, 2025, GPC granted restricted stock units (RSUs) with a grant date value of $3 million to its President and CEO and $1.5 million to each of the other named executive officers.",
                "3.  GPC's board adopted a form of severance agreement on September 4, 2025, offering payouts of up to two times the annual base salary plus target annual bonus for the CEO and one and a half times plus target bonus for other executives, in addition to other benefits, if terminated without cause or if the executive resigns for good reason."
            ]
        },
        {
            "company_name": "T. Rowe Price",
            "stock": "TROW",
            "wiki_url": "https://en.wikipedia.org/wiki/T._Rowe_Price",
            "change_percent": 0,
            "price": 105.36,
            "filing_type": "8-K",
            "filing_time": "2025-09-04T08:38:27-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1113169/000111316925000028/0001113169-25-000028-index.htm",
            "accession_number": "0001113169-25-000028",
            "summary_points": [
                "1. Goldman Sachs' planned investment of up to $1 billion in T. Rowe Price common stock was announced on September 4, 2025.",
                "2. As of July 31, 2025, T. Rowe Price managed $1.7 trillion in client assets, with roughly $1.13 trillion related to retirement.",
                "3. T. Rowe Price and Goldman Sachs plan to launch co-branded target-date retirement strategies including private market investments by mid-2026."
            ]
        },
        {
            "company_name": "Elevance Health",
            "stock": "ELV",
            "wiki_url": "https://en.wikipedia.org/wiki/Elevance_Health",
            "change_percent": 0,
            "price": 321.56,
            "filing_type": "8-K",
            "filing_time": "2025-09-04T06:02:07-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1156039/000115603925000129/0001156039-25-000129-index.htm",
            "accession_number": "0001156039-25-000129",
            "summary_points": [
                "1. Elevance Health, Inc. reaffirmed its 2025 shareholders' earnings guidance to be approximately $24.10 per diluted share, with adjusted earnings (excluding approximately $5.90 per diluted share of net unfavorable items) expected to be approximately $30.00 per diluted share.",
                "2.  The company anticipates a benefit expense ratio of approximately 90.0% for the full year 2025.",
                "3.  Elevance Health's actual results could materially differ from its current guidance due to changes in business factors or assumptions, including cost trends and medical claims payable estimates."
            ]
        },
        {
            "company_name": "Salesforce",
            "stock": "CRM",
            "wiki_url": "https://en.wikipedia.org/wiki/Salesforce",
            "change_percent": 0,
            "price": 256.47,
            "filing_type": "10-Q",
            "filing_time": "2025-09-03T21:41:22-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1108524/000110852425000088/0001108524-25-000088-index.htm",
            "accession_number": "0001108524-25-000088",
            "summary_points": [
                "Failed to analyze filing"
            ]
        },
        {
            "company_name": "Cisco",
            "stock": "CSCO",
            "wiki_url": "https://en.wikipedia.org/wiki/Cisco",
            "change_percent": 0,
            "price": 67.67,
            "filing_type": "10-K",
            "filing_time": "2025-09-03T16:52:59-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/858877/000085887725000111/0000858877-25-000111-index.htm",
            "accession_number": "0000858877-25-000111",
            "summary_points": [
                "1.  As of July 26, 2025, $1.6 billion in unrecognized tax benefits could impact the effective tax rate if realized.",
                "2.  The company's net deferred tax assets were $7.281 billion as of July 26, 2025, compared to $6.186 billion on July 27, 2024.",
                "3.  A $355 million charge was recorded in the fourth quarter of fiscal 2025 (ending July 26, 2025) due to a legal settlement with a supplier, offset by an $82 million income tax benefit."
            ]
        },
        {
            "company_name": "Cencora",
            "stock": "COR",
            "wiki_url": "https://en.wikipedia.org/wiki/Cencora",
            "change_percent": 0,
            "price": 295.03,
            "filing_type": "8-K",
            "filing_time": "2025-09-03T16:43:27-04:00",
            "filing_url": "https://www.sec.gov/Archives/edgar/data/1140859/000110465925087080/0001104659-25-087080-index.htm",
            "accession_number": "0001104659-25-087080",
            "summary_points": [
                "1. On September 3, 2025, Cencora, Inc. announced a settlement agreement, subject to court approval, resolving a stockholder derivative action related to oversight of controlled substance diversion programs; insurance carriers will pay the company $111.3 million, less any attorneys' fees and expenses.",
                "2. The settlement agreement, filed on August 15, 2025, and subject to court approval by November 13, 2025, involves a $111.3 million payment to Cencora, Inc.  This is a significant sum, representing a considerable portion of the company\u2019s potential liability.",
                "3.  The court approval process for the settlement agreement presents a risk to Cencora, Inc.; if the court rejects the settlement, the company faces continued legal costs and uncertainty regarding the final outcome of the lawsuit."
            ]
        }
    ]
}